Oue Lippo Healthcare Ltd
SGX:5WA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.025
0.031
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Oue Lippo Healthcare Ltd
Cash & Cash Equivalents
Oue Lippo Healthcare Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Oue Lippo Healthcare Ltd
SGX:5WA
|
Cash & Cash Equivalents
S$56.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
4%
|
|
|
Raffles Medical Group Ltd
SGX:BSL
|
Cash & Cash Equivalents
S$316.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
25%
|
CAGR 10-Years
9%
|
|
|
I
|
ISEC Healthcare Ltd
SGX:40T
|
Cash & Cash Equivalents
S$15.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
19%
|
|
|
A
|
Asia Vets Holdings Ltd
SGX:5RE
|
Cash & Cash Equivalents
S$8.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
6%
|
|
|
Thomson Medical Group Ltd
SGX:A50
|
Cash & Cash Equivalents
S$167.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
20%
|
|
Oue Lippo Healthcare Ltd
Glance View
OUE Lippo Healthcare Ltd. is as an investment holding company, which engages in the provision of healthcare services and facilities. The firm owns, operates and invests in healthcare businesses Asian markets. The Company’s segments include Healthcare operations, Healthcare assets, Properties under development and Investments. The Healthcare Operations segment includes the operation of hospitals and trading of pharmaceutical supplies and drugs and has operations in China and Myanmar. The Properties under development segment includes development of medical facilities, healthcare-related assets and integrated mixed-used projects and has development properties in China and Malaysia. The Healthcare assets segment includes rental of investment properties and assets owned by the Company and has assets in Japan and China. The Investments segment has investments in real estate investment trust (REIT) and REIT manager. OUELH also holds a 50% equity interest in China Merchants Lippo Hospital Management (Shenzhen) Limited (CM Lippo).
See Also
What is Oue Lippo Healthcare Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
56.7m
SGD
Based on the financial report for Jun 30, 2024, Oue Lippo Healthcare Ltd's Cash & Cash Equivalents amounts to 56.7m SGD.
What is Oue Lippo Healthcare Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
4%
Over the last year, the Cash & Cash Equivalents growth was -22%. The average annual Cash & Cash Equivalents growth rates for Oue Lippo Healthcare Ltd have been 21% over the past three years , 15% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
